Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
5.01
+0.02 (0.40%)
At close: Oct 29, 2025, 4:00 PM EDT
4.990
-0.020 (-0.40%)
Pre-market: Oct 30, 2025, 8:46 AM EDT

Taysha Gene Therapies Revenue

Taysha Gene Therapies had revenue of $1.99M in the quarter ending June 30, 2025, with 78.60% growth. This brings the company's revenue in the last twelve months to $8.10M, down -37.09% year-over-year. In the year 2024, Taysha Gene Therapies had annual revenue of $8.33M, down -46.07%.

Revenue (ttm)
$8.10M
Revenue Growth
-37.09%
P/S Ratio
170.75
Revenue / Employee
$110,932
Employees
73
Market Cap
1.37B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.33M-7.12M-46.07%
Dec 31, 202315.45M12.95M517.55%
Dec 31, 20222.50M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings